Quinoxalinone‐based, endoplasmic reticulum‐targeting photosensitizer nanoparticles for tumor photodynamic therapy
Bioengineering & Translational Medicine · 2026-11 · 11 (6)
DOI: 10.1002/btm2.70170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 09.08.2026. Verfasst von Chao Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy The Second Qilu Hospital of Shandong University Jinan China. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
The endoplasmic reticulum (ER) is an indispensable organelle responsible for the synthesis and transport of proteins and membrane lipids, playing a critical role in numerous physiological and pathological processes. Leveraging the properties of the ER, we developed novel quinoxalinone‐based, ER‐targeting photosensitizer nanoparticles (Qui‐PS NPs) by conjugating an ER‐specific targeting peptide(RACR) and evaluated their photodynamic therapy (PDT) efficacy. The size, morphology, cellular uptake, ER targeting capability, cell viability, biodistribution, and antitumor efficacy were assessed using dynamic light scattering, transmission electron microscopy, confocal microscopy, CCK‐8 assay, ICP‐Mass spectrometry, and tumor volume measurements, respectively. The results demonstrated that the synthesized Qui‐PS NPs possessed an average diameter of nm, a polydispersity index (PDI) of , and a Zeta potential of mV. These nanoparticles exhibited near‐infrared fluorescence emission centered at 830 nm and demonstrated superior singlet oxygen ( 1 O 2 ) generation capability. The NPs were readily internalized by MCF‐7 cells, displayed specific ER targeting, and induced cytotoxic effects upon light irradiation, with an value of μg/mL. In tumor‐bearing mice, Qui‐PS NPs preferentially accumulated in tumor tissue and significantly suppressed tumor progression under light irradiation, with minimal impact on body weight. These findings suggest that these ER‐targeted NPs represent a promising nanoplatform for potential application in tumor PDT.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy The Second Qilu Hospital of Shandong University Jinan China.
- Department of Spinal Surgery People's Hospital of Wudi Binzhou China.
- Department of Pharmacy Zibo Central Hospital Zibo China.
- Department of Spinal Surgery The Second Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University Jinan China.
Förderung
- Natural Science Foundation of Shandong Province
Zitieren
APA
Sun, C., Wang, L., Li, T., Duan, L., Dong, Y., & Li, J. (2026). Quinoxalinone‐based, endoplasmic reticulum‐targeting photosensitizer nanoparticles for tumor photodynamic therapy. Bioengineering & Translational Medicine, 11(6). https://doi.org/10.1002/btm2.70170
Vancouver
Sun C, Wang L, Li T, Duan L, Dong Y, Li J. Quinoxalinone‐based, endoplasmic reticulum‐targeting photosensitizer nanoparticles for tumor photodynamic therapy. Bioengineering & Translational Medicine. 2026;11(6). doi:10.1002/btm2.70170
BibTeX
@article{Sun2026,
author = {Sun, Chao and Wang, Lici and Li, Tao and Duan, Lei and Dong, Yan and Li, Ji},
title = {Quinoxalinone‐based, endoplasmic reticulum‐targeting photosensitizer nanoparticles for tumor photodynamic therapy},
journal = {Bioengineering & Translational Medicine},
year = {2026},
volume = {11},
number = {6},
doi = {10.1002/btm2.70170}
}
EUVIMED